Discontinuation report CEENU

Last updated on 2019-01-02 History
Report ID 48137
Drug Identification Number 00360414
Brand name CEENU
Common or Proper name Lomustine
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status CANCELLED POST MARKET
Active Ingredient(s) LOMUSTINE
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 BTL x 20
ATC code L01AD
ATC description ALKYLATINGAGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-08-30
Actual discontinuation date
Remaining supply date 2019-08-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply CEENU 10MG AND 40MG will still be available. Only the 100mg strength is being discontinued.
Company comments
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-01-02 French Compare
v5 2019-01-02 English Compare
v4 2018-12-03 French Compare
v3 2018-12-03 English Compare
v2 2018-05-02 French Compare
v1 2018-05-02 English Compare